Trials / Conditions / Glucose Transporter Type 1 Deficiency Syndrome

Glucose Transporter Type 1 Deficiency Syndrome

14 registered clinical trials studyying Glucose Transporter Type 1 Deficiency Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Suspended	Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome NCT04137692	Weill Medical College of Cornell University	N/A
Recruiting	Brain Metabolism Observed at 7 Tesla NCT05085704	University of Texas Southwestern Medical Center	—
Completed	Evaluation of Ketoflo NCT04399954	Vitaflo International, Ltd	N/A
Enrolling By Invitation	Early Check: Expanded Screening in Newborns NCT03655223	RTI International	—
Withdrawn	Evaluation of Krio in Children and Adults With Epilepsy NCT03202108	Vitaflo International, Ltd	N/A
Completed	Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) NCT03181399	University of Texas Southwestern Medical Center	Phase 2
Completed	Treatment Development of Triheptanoin (G1D) NCT03041363	Juan Pascual	Phase 1
Completed	Evaluation of Keyo in Children With Epilepsy NCT02915211	Vitaflo International, Ltd	N/A
Withdrawn	Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) NCT02021526	Juan Pascual	Phase 1 / Phase 2
Terminated	Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Synd NCT02599961	Ultragenyx Pharmaceutical Inc	Phase 2
Unknown	Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome NCT02000960	University of British Columbia	Phase 2
Completed	The Glucose Transporter Type I Deficiency (G1D) Registry NCT02013583	University of Texas Southwestern Medical Center	—
Completed	Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) NCT02018315	Juan Pascual	Phase 1
No Longer Available	Post Study Continuation of C7 for G1D NCT02018302	Juan Pascual	—